| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $43.9M | +99.0% |
| SG&A Expense | $29.7M | +125.1% |
| Operating Income | -$80.1M | -109.5% |
| Interest Expense | $200K | +124.7% |
| Pre-tax Income | $5.2M | +114.6% |
| Net Income | $5.2M | +114.6% |
| EPS (Basic) | $0.04 | +111.1% |
| EPS (Diluted) | $0.04 | +111.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $116.2M | -33.0% |
| Current Assets | $120.4M | -32.5% |
| Total Assets | $140.3M | -22.8% |
| Current Liabilities | $8.4M | +34.4% |
| Long-term Debt | $675K | +0.0% |
| Total Liabilities | $29.2M | -70.3% |
| Stockholders' Equity | $111.0M | +33.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.2M | -83.8% |
| Investing Cash Flow | -$5.4M | -315.2% |
| Financing Cash Flow | $9.1M | -95.2% |